Sandra Fujita
Psychiatric/Mental Health · Hialeah, FLNPI 1437160280
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,452, 6.3 times the $392 reported in 2021. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$981
- Teva Pharmaceuticals USA, Inc.$858
- Alkermes, Inc.$578
- Johnson & Johnson$578
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$521
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,99197%
- Education$2213%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,430 |
| Otsuka America Pharmaceutical, Inc. | 49 | $981 |
| Teva Pharmaceuticals USA, Inc. | 39 | $858 |
| Alkermes, Inc. | 31 | $578 |
| Johnson & Johnson | 30 | $578 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $521 |
| Indivior Inc. | 15 | $389 |
| E.r. Squibb & Sons, L.L.C. | 14 | $375 |
| Neurocrine Biosciences, Inc. | 16 | $314 |
| Almatica Pharma LLC | 14 | $300 |
| Lundbeck LLC | 11 | $249 |
| Vanda Pharmaceuticals Inc. | 9 | $205 |
| Axsome Therapeutics, Inc. | 6 | $160 |
| Ironshore Pharmaceuticals Inc. | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Tempus AI, Inc | 1 | $24 |
| Tris Pharma Inc | 1 | $22 |
| Braeburn Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
How this compares
$7,212 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 35 | $84,759 |
| RexultiBrexpiprazole | 56 | $81,817 |
| Invega SustennaPaliperidone Palmitate | 13 | $37,466 |
| Lurasidone Hcl | 89 | $28,426 |
| VraylarCariprazine Hcl | 15 | $20,717 |
| Aripiprazole | 177 | $15,337 |
| Chlorpromazine Hcl | 28 | $6,030 |
| Buspirone Hcl | 393 | $4,068 |
| Divalproex Sodium | 142 | $3,766 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 60 | $3,431 |
| Quetiapine Fumarate | 271 | $2,939 |
| Risperidone | 216 | $2,776 |
| Mirtazapine | 274 | $2,702 |
| Haloperidol | 41 | $1,897 |
| Fluoxetine Hcl | 184 | $1,541 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $981 | $166,57691 claims |
| Johnson & JohnsonInvega Sustenna | $578 | $37,46613 claims |
| AbbVieVraylar | $1,430 | $20,71715 claims |
| Almatica Pharma LLCSertraline Hcl | $300 | $380159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Hialeah
- Eudaldo AponteHialeah$214K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.